Background
Neural tube defects (NTDs) are the second most common birth defects in humans arising as a result of incomplete closure of the brain or spinal cord in the 3rd and/or 4th week of pregnancy [
1]. Nearly 200,000 neonates are estimated to be born each year with NTDs in low- and middle-income countries (LMICs) [
2]. Despite decades-old evidence that dietary supplementation with folic acid (FA) significantly decreases cases of NTDs and spina bifida, in particular, [
3] many sub-Saharan African countries have yet to mandate folic acid fortification of their grain products [
4]. Among children born with NTDs, mortality is over 75% before 5 years [
5]. In addition to causing stillbirths, neonatal, infant, and under-five mortality, NTDs significantly contribute to disability-adjusted life years and increases health care costs among survivors [
6].
After randomized clinical trials demonstrated the efficacy of periconceptional supplements with FA in preventing NTDs, [
3,
7] the U.S. Public Health Service recommended that all women capable of becoming pregnant consume 400 μg of folic acid daily to prevent neural tube defects [
8]. In 1996, the United States Food and Drug Administration required that manufacturers add 140
μg folic acid per 100 g of grain product labeled as enriched. As a result, NTDs prevalence decreased from 10.7 per 10,000 live births in 1995–1996 (before fortification) to 7.0 per 10,000 in 2009–2011 (after fortification) [
9]. However, in Eastern Africa, such mandates of fortification of grain do not exist or are not enforced [
10]. Furthermore, in Eastern Africa, most women do not realize that they are pregnant until after 28 days of gestation when the neural tube has closed. A critical timing to start FA supplementation is missed as pregnant women start taking the supplements in the second trimester when they attend antenatal care. In addition, women from lower socioeconomic status cannot afford relatively expensive foods such as dairy and meat products, which are rich sources of folic acid [
11]. Eastern Africa has one of the highest prevalences of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) in the world [
12]. Current recommendations for the treatment of HIV during pregnancy include taking antiretroviral therapy (ART) [
13]. However, ART has been associated with spinal tube defects recently [
14‐
16]. Taken together, these factors warrant determining the current prevalence rates of NTD in Eastern Africa to inform public health programs and policy and research activities.
To date, systematic reviews estimating the prevalence of NTDs have focused on high-income countries, in part due to a lack of studies in LMICs such as sub-Saharan Africa [
5]. Even with such increased risk factors of NTDs, we are not aware of population-based surveillance programs for NTDs in Eastern Africa. However, hospital-based surveillance programs are steadily increasing with a subsequent increase in the number of publications on the prevalence of NTDs. Therefore, we conducted a systematic review and meta-analysis to 1) estimate the birth prevalence of NTDs in Eastern Africa, 2) describe country-level differences in prevalence, and 3) establish a temporal trend for the birth prevalence.
Discussion
In this meta-analysis, the pooled birth prevalence of neural tube defects was 33 (95% CI: 22 to 51). The pooled prevalence of NTDs (60 per 10,000 births) was highest in Ethiopia and lowest in Malawi (5 per 10,000 births). The estimated point prevalence of spina bifida was two times higher than anencephaly and ten times higher than encephalocele.
The pooled prevalence of NTDs in Eastern Africa is nearly five times as high as that of the post-stratification era of the United States. In the United States, the transition to fortifying foods with folic acid substantially decreased the prevalence of NTDs in newborns. The Centers for Disease Control and Prevention reports that the proportion of babies with NTDs has decreased by 35% due to this implementation [
9]. While this change in legislation has ultimately benefited the United States population, this practice has not been adopted in all regions across the globe. The fortification of grains and other food products in Eastern Africa has not been widely adopted and may contribute to the growing birth prevalence of NTDs in the region.
Recently, a study of birth defects in infants born to women with HIV infection in Botswana reported an eightfold increased risk for NTDs among births with periconceptional exposure to ART that included integrase inhibitor dolutegravir (DTG) compared with other ART regimens [
14]. Although a recent surveillance study conducted in the United States did not find a difference in the birth prevalence of NTDs in HIV-exposed live births from that of the general population, [
45] it is possible that other confounders such as socioeconomic status may differ between Eastern Africa and the United States study population. Considering the high prevalence of HIV in Eastern Africa and the use of ART during the periconceptional period, it is plausible that these factors could contribute to the high birth prevalence of NTDs in this region. Furthermore, the high poverty rates, lack of NTDs awareness from public health campaigns could be the driving factors of the high prevalence of NTDs in Eastern Africa.
The results of this meta-analysis contribute to renewing the call for urgent actions to curb down NTDs burden in Eastern Africa. Effective public health interventions can be conceptualized at the patient/provider or a much larger regional or national level. Increasing awareness among patients and medical providers, including those in charge of prenatal care on the issue of NTDs, may translate into more use of folic acid periconceptually. This approach seems effortful and less likely to reach a sizable population at risk. Ideally, it should be preceded by recommendations from health authorities on the daily requirement of folic acid to achieve adequate NTDs prevention. Recommended daily intake for the primary prevention of NTDs among low-risk women before conception and throughout lactation is 400 micrograms internationally [
46]. A more pragmatic approach would require fortifying commonly used dietary products in each country. The experience of universal iodization has proven that such an epidemiological approach was feasible and efficient with most countries worldwide achieving iodization of at least 95% of all salt supplies. As a result, iodine deficiency, the most important preventable cause of acquired intellectual disability, has been virtually eliminated [
47]. The successful elimination of iodine deficiency required the commitment of world political leaders. Similarly, fortifying foods with folic acid is more likely to be successful with the implication of local-, regional- and country-level political and healthcare stakeholders.
In the context of priority-based budgeting, financing nutrient fortification programs with folic acid require demonstrating the strategy’s cost-effectiveness. Although such data are scarce in Eastern African countries, estimates from the United States where the program has been successfully implemented are compelling. For example, after folic acid fortification, between 600 and 700 babies were born each year without spina bifida, translating into $400 million to $600 million saved every year in the United States [
48]. Altogether, identifying universally consumed nutrients in Eastern Africa or each specific country and fortifying them with folic acid appears to offer the best chances to reduce the burden of NTDs.
Public health implications of our findings
Establishing national and regional registries and harmonizing and improving diagnostic criteria would result in a better estimation of the disease burden. Some populations at risk will need special attention, including childbearing age women with epilepsy. They will need to be systematically identified and followed up, preferably by providers with epilepsy-care experience through a well-structured referral system. The prevalence of the use of antiepileptic drugs with high teratogenic potential will need to be established. Additionally, besides benefiting from fortified nutrients, those women will need to take folic supplements peri-conceptually. Finally, for children born with NTDs, prompt referral to specialized centers will need to be made as soon as the disease is detected.
Strengths and weakness
The results of the present meta-analysis should be interpreted in the context of potential limitations. First, the current meta-analysis relied on the quality of published literature. Cases of neural tube defects may be difficult to ascertain due to neuro-imaging equipment and neurologist/neurosurgeon scarcity. Therefore, the estimates of the current meta-analysis are likely conservative; the true incidence of NTDs in Eastern Africa is probably much higher. Second, various Eastern African countries were combined to provide pooled estimates of NTDs. Potential differences in genetics and diet across these geographic regions could have introduced variations in the estimates. Nevertheless, random-effects models were adopted to control for the possible difference in effect estimates. Lastly, only 6 countries out of 20 countries in the United Nations Eastern African region were represented in the current meta-analysis. Generalizing the current estimates to the rest of Eastern Africa countries should be done with caution. The strength of our meta-analysis lies in the literature search rigor in more than two databases and the robust statistical methods we applied. Therefore, these estimates are informed by the best, most up-to-date, and most diversified data available and can be used to guide future assessment of the economic burden of NTDs in Eastern Africa.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.